Image analysis quantification of substance P immunoreactivity in the trapezius muscle of patients with fibromyalgia and myofascial pain syndrome

Journal of Rheumatology

Volumn 27, Issue 12, 2000, Pages 2906-2910

  De Stefano, R ^a   Selvi, E ^a   Villanova, M ^a   Frati, E ^a   Manganelli, S ^a   Franceschini, E ^a   Biasi, G ^a   Marcolongo, R ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Fibromyalgia; Skeletal muscle; Substance P

Indexed keywords

SUBSTANCE P;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROMYALGIA; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MYOFASCIAL PAIN; PAIN; PATHOGENESIS; PRIORITY JOURNAL; SKELETAL MUSCLE; TRAPEZIUS MUSCLE;

ADULT; ANALYSIS OF VARIANCE; FEMALE; FIBROMYALGIA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUSCLE, SKELETAL; MYOFASCIAL PAIN SYNDROMES; NEURONS, AFFERENT; SUBSTANCE P;

EID: 0033663967     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Fibromyalgia and related syndromes
2. Clinical and aetiological update of myofascial pain from trigger points
3. Primary fibromyalgia. A clinical and laboratory study of 55 patients
4. Postural and mechanical factors in localized and generalized fibromyalgia syndrome
5. Can fibromyalgia be separated from regional pain syndrome affecting the arm?
6. Generalized pain, fibromyalgia and regional pain: An epidemiological view
7. Fibromyalgia: The clinical syndrome
8. Fibromyalgia is not a muscular disorder
9. Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism
10. Neurochemical pathogenesis of fibromyalgia syndrome
11. Elevated CSF levels of SP and high incidence of Raynaud's phenomenon in patients with fibromyalgia: New features for diagnosis
12. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome
13. Substance P, 5-HIAA and tryptophan in serum of fibromyalgia patients
14. Plasma substance P levels in fibrositis
15. Immunohistochemical and molecular studies of serotonin, substance P, galanin, pituitary adenyl cyclase-activating polypeptide, and secretoneurin in fibromyalgia muscle tissue
16. The American College Of Rheumatology 1990 criteria for the classification of fibromyalgia
17. Quantitative immunocytochemistry
18. Review of the effectiveness of capsaicin for painful cutaneous disorders and neural dysfunction
19. Treatment of reflex sympathetic distrophy with topical capsaicin: A case report
20. The postmastectomy pain syndrome and topical capsaicin: Randomized trial
21. Electronmicroscopic studies of muscle biopsy in primary fibromyalgia syndrome: A controlled and blinded study
22. Mitochondrial myopathy mimicking a fibromyalgia syndrome
23. Secondary hyperalgesia and perceptual wind-up following intradermal injection of capsaicin in humans
24. Calcitonin gene related peptide neurokinin A and substance P. Effects on nociception and neurogenic inflammation in human skin and temporal muscle
25. Increased neurogenic inflammation in fibrositis syndrome
26. Diagnostic epidural opioid blockade in primary fibromyalgia at rest and during exercise
27. Nociception from skeletal muscle in relation to clinical muscle pain
28. Receptor endocytosis and dendrite reshaping in spinal neurones after somatosensory stimulation
29. Response behaviour of cat dorsal horn neurones receiving input from skeletal muscle and other deep somatic tissues
30. Spinal modulation of the induction of central sensitization
31. Contribution of central neuroplasticity to pathological pain: Review of clinical and experienced evidence
32. Substance P effect on spinal nociceptive neurones
33. The contribution of muscle to the generation of fibromyalgia symptomatology
34. Clinical update on other pain syndromes
35. Neuroendocrine abnormalities in fibromyalgia and related disorders
36. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia
37. Nerve growth factor induced hyperalgesia in the neonatal and adult rat
38. Nerve growth factor and nociception
39. 7
40. Spinally administered dynorphin A produces long lasting allodynia: Involvement of NMDA but not opioid receptors
41. Relationship of clinical features with psychological status in primary fibromyalgia